This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Cancers of the digestive system are a group of cancers that affect the organs of the digestive system. This includes the esophagus, stomach, small intestine, large intestine, rectum, liver, pancreas, and gallbladder. These cancers can be further classified by the type of cell that is affected. The most common types of digestive system cancers are adenocarcinomas, which start in the cells that line the digestive organs, and sarcomas, which start in the connective tissues of the organs. The cause of digestive system cancers is not fully understood, but certain risk factors are associated with increased risk. These include age, smoking, alcohol consumption, and certain medical conditions. Genetics can also play a role in the development of digestive system cancers. The symptoms of digestive system cancers vary depending on the type and location of the cancer. Common symptoms include pain, difficulty swallowing, abdominal pain, blood in the stool, weight loss, and nausea. If any of these symptoms are present, a doctor should be consulted. Diagnosis of digestive system cancers is done through imaging tests, endoscopy, and biopsy. Treatment for digestive system cancers depends on the type, size, and location of the cancer. Options include surgery, chemotherapy, radiation therapy, and targeted therapy. It is important to discuss the risks and benefits of each treatment option with a doctor before making a decision. Preventing digestive system cancers is the best way to reduce the risk. This includes avoiding the risk factors mentioned above, getting regular check-ups and screenings for early detection, and eating a healthy diet. Digestive system cancers are serious and can be life-threatening if not caught and treated early. Knowing the risk factors and symptoms is important for early diagnosis and treatment. Working with a doctor to create an individualized treatment plan is the best way to ensure the best possible outcome.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States